Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-06 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
| 2024-10-04 | New | $1,250,000 | $1,250,000 | Equity Only | 06b | SEC link |
| 2024-02-23 | New | $10,193,654 | $10,193,654 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Brian G. Atwood | Director |
| Michael Byrnes | Director |
| Chris Ehrlich | Director, Executive |
| Andrew Albert Kucharchuk | Executive |
| Kathleen La Porte | Director |
| Shami Patel | Director |
| Kristen Pierce | Executive |
| Robyn Rapaport | Director |
| Lindsey Rolfe | Director |